Bijvoet OL - Search Results

1

Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate.

Schweitzer DH, Zwinderman AH, Vermeij P, Bijvoet OL, Papapoulos SE. Schweitzer DH, et al. Among authors: bijvoet ol. J Bone Miner Res. 1993 Feb;8(2):175-82. doi: 10.1002/jbmr.5650080208. J Bone Miner Res. 1993. PMID: 8442435

2

Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphosphonate.

Papapoulos SE, Hoekman K, Löwik CW, Vermeij P, Bijvoet OL. Papapoulos SE, et al. Among authors: bijvoet ol. J Bone Miner Res. 1989 Oct;4(5):775-81. doi: 10.1002/jbmr.5650040518. J Bone Miner Res. 1989. PMID: 2816519

3

Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD.

Valkema R, Vismans FJ, Papapoulos SE, Pauwels EK, Bijvoet OL. Valkema R, et al. Among authors: bijvoet ol. Bone Miner. 1989 Jan;5(2):183-92. doi: 10.1016/0169-6009(89)90095-0. Bone Miner. 1989. PMID: 2920240

4

Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).

Harinck HI, Papapoulos SE, Blanksma HJ, Moolenaar AJ, Vermeij P, Bijvoet OL. Harinck HI, et al. Among authors: bijvoet ol. Br Med J (Clin Res Ed). 1987 Nov 21;295(6609):1301-5. doi: 10.1136/bmj.295.6609.1301. Br Med J (Clin Res Ed). 1987. PMID: 3120987 Free PMC article.

5

Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD.

Papapoulos SE, Harinck HI, Bijvoet OL, Gleed JH, Fraher LJ, O'Riordan JL. Papapoulos SE, et al. Among authors: bijvoet ol. Bone Miner. 1986 Feb;1(1):69-78. Bone Miner. 1986. PMID: 3508718

6

Palliative pamidronate treatment in patients with bone metastases from breast cancer.

van Holten-Verzantvoort AT, Kroon HM, Bijvoet OL, Cleton FJ, Beex LV, Blijham G, Hermans J, Neijt JP, Papapoulos SE, Sleeboom HP, et al. van Holten-Verzantvoort AT, et al. Among authors: bijvoet ol. J Clin Oncol. 1993 Mar;11(3):491-8. doi: 10.1200/JCO.1993.11.3.491. J Clin Oncol. 1993. PMID: 7680374 Clinical Trial.

7

The use of bisphosphonates in the treatment of osteoporosis.

Papapoulos SE, Landman JO, Bijvoet OL, Löwik CW, Valkema R, Pauwels EK, Vermeij P. Papapoulos SE, et al. Among authors: bijvoet ol. Bone. 1992;13 Suppl 1:S41-9. doi: 10.1016/s8756-3282(09)80009-4. Bone. 1992. PMID: 1581119 Review.

8

Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants.

van der Pluijm G, Löwik CW, de Groot H, Alblas MJ, van der Wee-Pals LJ, Bijvoet OL, Papapoulos SE. van der Pluijm G, et al. Among authors: bijvoet ol. J Bone Miner Res. 1991 Nov;6(11):1203-10. doi: 10.1002/jbmr.5650061110. J Bone Miner Res. 1991. PMID: 1839590

9

Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatment.

Papapoulos SE, Frolich M, Mudde AH, Harinck HI, vd Berg H, Bijvoet OL. Papapoulos SE, et al. Among authors: bijvoet ol. J Clin Endocrinol Metab. 1987 Jul;65(1):89-94. doi: 10.1210/jcem-65-1-89. J Clin Endocrinol Metab. 1987. PMID: 3495547

10

Bisphosphonates in osteoporosis?

Bijvoet OL, Valkema R, Löwik CW, Papapoulos SE. Bijvoet OL, et al. Osteoporos Int. 1993;3 Suppl 1:230-6. doi: 10.1007/BF01621915. Osteoporos Int. 1993. PMID: 8461570 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters